Determination of tumor necrosis factor-alpha (TNF-alpha) in serum by a highly sensitive enzyme amplified lanthanide luminescence immunoassay.
暂无分享,去创建一个
[1] N. Donato,et al. Tumor Necrosis Factor-induced Apoptosis Stimulates p53 Accumulation and p21WAF1 Proteolysis in ME-180 Cells* , 1998, The Journal of Biological Chemistry.
[2] D. Heney,et al. Factors Affecting the Measurement of Cytokines in Biological Fluids: Implications for Their Clinical Measurement , 1995, Annals of clinical biochemistry.
[3] W. Fiers,et al. Molecular mechanisms of tumor necrosis factor‐induced cytotoxicity , 1994, FEBS letters.
[4] C. Smith,et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. , 1990, Science.
[5] Bharat B. Aggarwal. Structure of tumor necrosis factor and its receptor , 1991, Biotherapy.
[6] M. Sharief,et al. Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .
[7] J. Elborn,et al. Can tumor necrosis factor‐α (TNF‐α) be reliably measured in blood? , 1995, Pediatric pulmonology.
[8] P. Heinrich,et al. Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.
[9] T. K. Christopoulos,et al. Quantitative polymerase chain reaction using a recombinant DNA internal standard and time-resolved fluorometry. , 1996, Analytical chemistry.
[10] P. C. Ioannou,et al. Second derivative synchronous scanning fluorescence spectrometry as a sensitive detection technique in immunoassays. Application to the determination of α-fetoprotein , 1994 .
[11] R. Heller,et al. Tumor necrosis factor receptor-mediated signaling pathways , 1994, The Journal of cell biology.
[12] K. Tracey,et al. Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.
[13] K. Tracey,et al. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.
[14] H. Redl,et al. Special collection and storage tubes for blood endotoxin and cytokine measurements. , 1992, Clinical chemistry.
[15] E. Diamandis,et al. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. , 1992, Analytical chemistry.
[16] J. Sjölin,et al. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. , 1995, The Journal of infectious diseases.
[17] N. Liabakk,et al. A rapid and sensitive immunoassay for tumor necrosis factor using magnetic monodisperse polymer particles. , 1990, Journal of immunological methods.
[18] P. C. Ioannou,et al. A highly sensitive enzyme-amplified lanthanide luminescence immunoassay for interleukin 6. , 1998, Clinical chemistry.
[19] R. Evangelista,et al. Enzyme-amplified lanthanide luminescence for enzyme detection in bioanalytical assays. , 1991, Analytical biochemistry.
[20] J. Strickler,et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. , 1985, Science.
[21] M. Remberger,et al. TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD. , 1995, Bone marrow transplantation.
[22] C. Maury,et al. Radioimmunoassay of tumor necrosis factor in serum. , 1987, Clinical chemistry.
[23] S. Joel,et al. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. , 1992, Journal of immunological methods.
[24] B. Aggarwal,et al. Tumor necrosis factors: developments during the last decade. , 1996, European cytokine network.
[25] W. R. Lamb,et al. A peroxidase-linked enzyme immunoassay for tumour necrosis factor alpha utilising alternative colorimetric or chemilumimetric substrates. , 1992, Journal of immunological methods.
[26] J. Cavaillon,et al. Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. , 1995, Journal of immunological methods.
[27] B. Millar,et al. Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. , 1992, Journal of immunological methods.
[28] N. Voitenok,et al. Homologous ELISA for detection of oligomeric human TNF: properties of the assay. , 1995, Journal of immunological methods.
[29] A. Cunningham,et al. The effect of alpha 2 macroglobulin in commercial cytokine assays. , 1994, JIM - Journal of Immunological Methods.
[30] M. Kurimoto,et al. A new highly sensitive immunoassay for cytokines by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). , 1992, Journal of immunological methods.
[31] E. Diamandis. Europium and terbium chelators as candidate substrates for enzyme-labelled time-resolved fluorimetric immunoassays , 1992 .
[32] J. Reinsberg. Interferences with two-site immunoassays by human anti-mouse antibodies formed by patients treated with monoclonal antibodies: comparison of different blocking reagents. , 1998, Clinical chemistry.
[33] P. Hilliquin,et al. Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids. , 1995, Scandinavian journal of rheumatology.
[34] A. Meager,et al. Assays for tumour necrosis factor and related cytokines. , 1989, Journal of immunological methods.
[35] C. E. Efstathiou,et al. Comparative study of fluorescent ternary terbium complexes. Application in enzyme amplified fluorimetric immunoassay for α-fetoprotein , 1996 .